Could you help unlock cancer genetics? NCI launches screening survey
NCT ID NCT07005297
First seen Nov 01, 2025 · Last updated Jun 20, 2026 · Updated 41 times
Summary
This study screens up to 1,000 people with personal or family histories of certain cancers or genetic syndromes to see if they qualify for one of six ongoing NCI genetics research studies. Participants fill out a 15-20 minute online questionnaire about their health, family history, and genetic test results. If eligible, they may be invited to join a study that involves providing medical records, samples, or interviews. No treatments are offered.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MELANOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
National Cancer Institute
Rockville, Maryland, 20850, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.